Exozymes Inc. has been selected as a core industry partner in the Meta-PURE initiative, a $9.2 million project funded by the National Science Foundation (NSF) under the CFIRE program. The initiative, led by Georgia Tech and involving a coalition of top academic and industry groups, aims to advance modular cell-free biomanufacturing. Exozymes Inc. will receive a $3 million share of the funding to develop a cell-free ATP-generating module, which will serve as a power plant for various chemical production modules. The company's involvement also includes creating a production module for santalene, a high-value fragrance compound. The project emphasizes the development of standardized, interoperable modules for diverse applications, enhancing the scalability and accessibility of cell-free systems.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。